GM25172
LCL from B-Lymphocyte
Description:
NEMALINE MYOPATHY 2, AUTOSOMAL RECESSIVE; NEM2
NEBULIN; NEB
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific PIGI Consented Sample |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
More than one race
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
Chinese/Ashkenazi Jewish
|
Country of Origin
|
USA
|
Family Member
|
1
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
NEB |
Chromosomal Location |
2q23.3 |
Allelic Variant 1 |
; NEMALINE MYOPATHY 2 (NEM2) |
Identified Mutation |
c.9619-2A>G |
|
Gene |
NEB |
Chromosomal Location |
2q23.3 |
Allelic Variant 1 |
p.His8159GlnfsStop8; NEMALINE MYOPATHY 2 (NEM2) |
Identified Mutation |
c.24473_24476dupAACA |
Remarks |
Clinically affected; symptom onset at birth; achieved/maintained motor functions: held head up without assistance, turned in bed without assistance at age 6 months, sat without assistance at age 8 months, stood without assistance at age 1.5 years, walked with assistance at age 2 years, walked indoors and outdoors unassisted at age 2 years old; gene sequencing of TPM3,TPM2 and NEB genes identified heterozygous mutation defined as c.9619-2A>G near the junction of intron 66 and exon 67 of the NEB gene; subject is also heterozygous for mutation defined as c.24473_24476dupAACA which is predicted to result in a frame shift and premature protein termination (p.His8159GlnfsStop8); respiratory support used during perinatal period; fibroblast is GM26093. |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|